MedTrace Logo

External Validation of the Beta-lactam Target Non-attainment (BATMAN) Risk Score in Adult ICU Patients: a Diagnostic Multivariate Predictive Risk Model

NCT05542771 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 130

Last updated 2023-05-25

No results posted yet for this study

Summary

Intensive care (IC) patients regularly get infections. Sometimes it is even the reason of admission to the intensive care unit. To treat these infections, we give medicines called antibiotics, such as β-lactams antibiotics. Every IC patient receives the same dose of β-lactams antibiotics, while we know this can lead to undertreatment in some IC patients. The BATMAN risk score was created to predict which IC patient is undertreated. This study aims to validate the BATMAN risk score so it can be used in clinical practice.

Conditions

  • Infection, Bacterial
  • Beta-lactam Antibiotics
  • Critical Care
  • Risk Model
  • Therapeutic Drug Monitoring

Sponsors & Collaborators

  • Chantal Kats

    lead OTHER

Principal Investigators

  • Alan Adulla, PhD · Erasmus Medical Center

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-04-24
Primary Completion
2023-10-01
Completion
2023-11-01

Countries

  • Netherlands

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05542771 on ClinicalTrials.gov